Medikamentöse Behandlung von Mukoviszidose – Kostenstruktur und Einsparpotenzial der ambulanten Behandlung

Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis

(2010) Susannah MAXWELL et al.   AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY

Outpatient Medication Costs of Patients with Cystic Fibrosis in Germany

(2010) Daniela Eidt-Koch et al.   Applied Health Economics and Health Policy

Pricing of orphan drugs

(2009) JV Leonard et al.   LANCET

Evaluation von Kosten der ambulanten Behandlung bei Mukoviszidose in Deutschland

(2009) Daniela Eidt et al.   MEDIZINISCHE KLINIK

Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report

(2009) Michael Drummond et al.   VALUE IN HEALTH

Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network

(2008) Laure Huot et al.   Journal of Cystic Fibrosis